{
  "run_id": "RUN_20260204_234342_996d5a3920e1",
  "timestamp": "2026-02-05T05:23:12.156415",
  "document": "Epidermolysis-Bullosa.pdf",
  "document_path": "/Users/frederictetard/Projects/ese/gold_data/NLP4RARE/train/Epidermolysis-Bullosa.pdf",
  "pipeline_version": "0.8",
  "total_recommendation_sets": 1,
  "total_recommendations": 2,
  "recommendation_sets": [
    {
      "guideline_name": "Not specified",
      "guideline_year": null,
      "organization": "Not specified",
      "target_condition": "Epidermolysis Bullosa (EB)",
      "target_population": null,
      "recommendations": [
        {
          "recommendation_id": "rec_Epidermolysis-Bullosa_1",
          "recommendation_type": "treatment",
          "population": "patients with suspected EB",
          "condition": "suspected epidermolysis bullosa",
          "severity": "not specified",
          "action": "avoid clinical diagnosis based on neonatal presentation",
          "action_description": null,
          "preferred": "not specified",
          "alternatives": [],
          "dosing": [],
          "taper_target": "not applicable",
          "duration": "not applicable",
          "stop_window": null,
          "evidence_level": "expert_opinion",
          "strength": "strong",
          "references": [],
          "source": "Epidermolysis-Bullosa",
          "source_text": "Clinical diagnosis of the type of EB based on presentation in the neonatal period should be avoided as all types of EB may look alike in this age group",
          "page_num": null
        },
        {
          "recommendation_id": "rec_Epidermolysis-Bullosa_2",
          "recommendation_type": "treatment",
          "population": "patients with suspected EB",
          "condition": "suspected epidermolysis bullosa",
          "severity": "not specified",
          "action": "obtain skin biopsy for confirmation with TEM and/or immunofluorescent antibody/antigen mapping",
          "action_description": null,
          "preferred": "skin biopsy with TEM and/or immunofluorescent mapping",
          "alternatives": [],
          "dosing": [],
          "taper_target": "not applicable",
          "duration": "not applicable",
          "stop_window": null,
          "evidence_level": "expert_opinion",
          "strength": "strong",
          "references": [],
          "source": "Epidermolysis-Bullosa",
          "source_text": "When EB is suspected, a skin biopsy should be obtained and sent to an appropriate laboratory to confirm the diagnosis with transmission electron microscopy (TEM) and/or immunofluorescent antibody/antigen mapping",
          "page_num": null
        }
      ],
      "source_document": "Epidermolysis-Bullosa",
      "extraction_confidence": 0.85
    }
  ]
}